As Syrian rebels reported uncovering significant stockpiles of Captagon, a potent illegal amphetamine, within a warehouse on the outskirts of Damascus, the implications for the country’s future are profound. For over thirteen years, the ongoing civil war has not only devastated the landscape but also transformed Syria into a narcostate, with Captagon driving a significant portion of its economy.
Originally created in Germany during the early 1960s as a treatment for attention deficit hyperactivity disorder and similar conditions, Captagon—known generically as fenethylline—was banned by most countries by the 1980s due to its high potential for addiction and severe side effects, which include psychosis and severe anxiety. Today, illicit Captagon often consists of a blend of various amphetamines, caffeine, and inexpensive fillers, enabling its mass production at minimal costs. In Syria, these pills can be produced for mere pennies but are sold on the streets for anywhere from $3 to $20, revealing a lucrative market worth billions.
This burgeoning trade has political undertones, as much of the trafficking is said to be controlled by allies and family members of former President Bashar al-Assad. The evidence of Captagon trafficking and its heroines ties into the wider scope of the war and the socio-economic chaos that has ensued.
With Syria facing a pivotal moment in its leadership, questions arise: Will the new leaders attempt to dismantle these drug networks, or will they perpetuate the criminal schemes that have entrenched their predecessors? As rebel forces continue to uncover the extent of this illicit trade, the international community watches closely, hoping for a shift that might also echo in broader efforts against drug trafficking in war zones worldwide.
